Objective: The study objective was to evaluate the impact of various surgical characteristics and practices on the risk of postoperative atrial fibrillation and other adverse outcomes after cardiac surgery.
Postoperative atrial fibrillation (PoAF) or flutter complicates approximately one third of cases of cardiac surgery and is associated with major adverse consequences, including prolonged in-hospital length of stay, increased health care costs, and increased rehospitalization rates. [1] [2] [3] Cardiac surgery is associated with direct and indirect myocardial injuries that are potential stimuli for adverse atrial remodeling and may increase arrhythmic risk. 1, 2, 4, 5 Thus, it is unsurprising that high rates of atrial fibrillation occur after cardiac surgery. However, there are scant contemporary data on how various surgery characteristics contribute to this risk, limiting the development of effective predictive and preventive measures.
Most earlier studies evaluating the risk of PoAF focused mainly on patient factors. [6] [7] [8] [9] [10] [11] In addition, the few studies evaluating the surgical characteristics in relation to PoAF were restricted in the scope of surgery types (eg, most only evaluated coronary artery bypass graft [CABG] procedures) and patient populations (eg, single country), limiting the generalizability of their findings. [12] [13] [14] [15] Furthermore, many of these analyses were performed using historical data, limiting relevance to modern surgical procedures.
Because of these issues, evidence on surgery characteristics is lacking in most risk-prediction tools for PoAF, 7, 16, 17 representing an important missed opportunity to improve patient care and outcomes. A better understanding of how surgery characteristics affect the risk of PoAF will help inform appropriate patient screening and counseling, as well as guidelines for surgical practice.
We performed a detailed investigation of how surgery characteristics relate to the incidence of PoAF using the prospectively collected data of the Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation (OP-ERA) trial, a large, multinational study of contemporary patients undergoing cardiac surgery that showed perioperative fish oil supplementation did not significantly affect the incidence of PoAF. In addition, we evaluated the impact of PoAF and other surgical and patient characteristics on inhospital major adverse cardiovascular events (MACE), postoperative mortality, and resource use to provide evidence on how these characteristics may relate to other common complications in a contemporary surgical population.
MATERIALS AND METHODS Study Design and Patients
This study was performed using the prospectively collected database of the OPERA trial, 18 a randomized, double-blind, placebo-controlled trial that showed that perioperative fish oil supplementation did not significantly affect the incidence of PoAF. The design and primary results have been reported in detail. 18, 19 Briefly, 1516 patients scheduled for cardiac surgery were enrolled across 28 centers in 3 countries (United States, Italy, and Argentina) between 2010 and 2012. Broad inclusion criteria captured a generalizable patient population: age 18 years or more; scheduled for cardiac surgery (any combination of CABG, valve surgery, or other cardiac surgery opening the pericardium); and sinus rhythm at enrollment. Exclusion criteria were regular use (!3 days/week) of fish oil within the prior 4 weeks; known allergy to fish oil or olive oil (placebo); unable or unwilling to provide informed written consent; being currently pregnant; or having an existing or a planned cardiac transplant or use of ventricular assist device. The study was approved by the human subjects committees of all participating institutions, and all patients provided written informed consent. The present investigation used available data on all patients (n ¼ 1462) who underwent cardiac surgery after enrollment.
Surgery Characteristics
Cardiac surgeries and postoperative care were performed in the OPERA trial to approximate real-world clinical practices, and no rigid protocol control that deviated from norm was used, for example, treating physicians could use beta-blockers or amiodarone as part of their usual clinical practices. With the use of standardized electronic data-collection sheets, details of surgery characteristics were prospectively collected for all patients in the OPERA trial. Examples of evaluated characteristics included type of surgery (eg, CABG, valvular surgery, various combinations), types and numbers of bypass grafts and target valves, access procedure (eg, open, mini thoracotomy), bypass characteristics (cardiopulmonary bypass, offpump vs on-pump CABG, duration of pump time, duration of crossclamp time), cardioplegia use, and method of return of rhythm after surgery (spontaneous vs assisted). The assisted method of rhythm return includes defibrillation, atrial pacing, and ventricular pacing. In patients requiring the assisted method of return of rhythm, the last method used immediately before the return of rhythm was defined as the method of rhythm return irrespective of other methods that had been tried.
End Points
The primary end point for this trial was the occurrence of PoAF of at least 30 seconds duration and documented by rhythm strip or 12-lead Table E1 .
Covariates
Standardized data were collected on demographics, cardiovascular risk factors, major comorbidities, medical and surgical history, anthropometric measurements, medication use (outpatient and inpatient), echocardiographic evaluation, and baseline laboratory indices. Daily follow-up and discharge information were recorded.
Statistical Analysis
To compare baseline characteristics between patients with and without PoAF, we used the chi-square test for categoric variable. For the continuous variables, normality of distribution was evaluated graphically and tested using the Skewness/Kurtosis test. Normally distributed variables were reported as mean (AE standard deviation [SD] ) and compared between the 2 groups using unpaired t test. On the other hand, non-normally distributed variables were reported as median with interquartile range and compared between the 2 groups using Wilcoxon rank-sum test. The association between surgery characteristics and incidence of PoAF was assessed in 2 stages via logistic regression. First, we evaluated each surgery characteristics separately in a multivariable model that adjusted for covariates consistently associated with the risk of PoAF in the past, including age, sex, race, history of atrial fibrillation, left atrial diameter, and chronic obstructive pulmonary disease (COPD). Additional evaluated covariates included country of enrollment, body mass index, smoking status, hypertension, prevalent heart failure, prevalent renal failure, prior percutaneous coronary intervention, baseline use of antiarrhythmic, and perioperative use of beta-blockers and statins, each considered for inclusion using a backward selection procedure (P exclusion ¼ .20, P inclusion ¼ .10). In addition, we evaluated for potential interactions (effect modification) between each surgery characteristic and clinically relevant factors, including age, sex, and race. Interactions were evaluated by introducing a multiplicative interaction term for the continuous form of age in the model; for the binary form within categories of age (!65 years vs < 65 years), sex, and race; and evaluating the significance of this term using the Wald test in the multivariable model. Second, to identify independent predictors of PoAF, we combined all surgery characteristics (evaluated among the entire patient population) and covariates that showed some univariate association with PoAF (ie, with P <.2) in a logistic prediction model. However, variables evaluated only among subgroups of the patient population, for example, off-pump (vs on-pump) CABG (which was evaluated only among patients undergoing CABG), were not considered for inclusion in this prediction model because including them would restrict the analysis to only patients within the subgroup. The overall predictive ability of the model was assessed using the C-statistic and interactions were tested as described. The association between surgery characteristics and other secondary end points were similarly evaluated using logistic regression and covariates adjustments as described. The cumulative incidence of surgery characteristics that independently predicted primary or secondary end points were further displayed via the Kaplan-Meier method.
To assess the impact of surgical characteristics and PoAF on MACE, mortality, and hospital length of stay, we used logistic regression (for MACE), Cox proportional hazard model (for mortality), and linear regression (for length of stay), with PoAF as 1 independent variable in a multivariable model. Proportional hazard assumption of the Cox model was tested via Schoenfeld residuals, whereas linearity and homoscedasticity assumptions of the linear regression model were evaluated via plot of the model residuals with the predictor variables and fitted lines, respectively. Covariate data were available in most patients, with rare missing values for body mass index (0.7%), baseline antiarrhythmic medication use (3.8%), perioperative beta-blocker (3.8%) and statin (1.1%) use, and method for rhythm return (3.5%), and more commonly missing data for preoperative left atrial diameter (32%). For each of these, we performed multivariate multiple imputations using available information from other variables (ie, age, sex, race, history of atrial fibrillation, COPD, smoking status, hypertension, heart failure, renal failure, prior percutaneous coronary intervention, incident PoAF, mortality, and length of stay) to account for the missing values. Multiple imputations were performed using the chained equations procedure via linear regression for body mass index and left atrial diameter, logistic regression for beta-blocker and antiarrhythmic use, and multinomial regression for rhythm return method. 20 For a sensitivity analysis, we performed complete case analysis for all end points using only nonmissing covariates. All analyses were performed using STATA 14 (StataCorp, LP, College Station, Tex), 2-tailed a ¼ 0.05.
RESULTS
Of the 1462 patients who underwent cardiac surgery in the OPERA trial, mean (SD) participant age was 64 (13) years, 72% were men, and cardiovascular risk factors were common among the participants (Table 1) . CABG and valvular surgery were the most common types of cardiac surgery performed; 601 of the patients underwent isolated CABG, 479 patients underwent isolated valvular surgery, 139 patients underwent combination of CABG and valvular surgery, and 23 patients underwent a combination of CABG, valvular, and at least 1 other procedure. Among all cardiac surgeries performed, cardiopulmonary bypass was used in 1252 patients (86%), in whom 97% involved the use of cardioplegic solutions. Other details of surgery and postoperative medications are shown in Table  E2 . During follow-up, a total of 460 cases of PoAF (31% of subjects), 356 cases of PoAF NT (24%), 33 cases of MACE (2.3%), 23 30-day deaths (1.6%), and 46 1-year deaths (3.1%) occurred. The mean (SD) ICU/CCU length-of-stay was 2.7 (2.2) days, and total hospital stay was 10 (5.8) days.
Surgical and Patient Characteristics and Risk of Postoperative Atrial Fibrillation
The incidence of PoAF increased from the day of surgery to a peak on postoperative day 2 and declined steadily thereafter ( Figure E1 ). When we evaluated the association between each surgery characteristic and incidence of PoAF, 4 major surgery characteristics-type of surgery, use of cardiopulmonary bypass, cardioplegia, and off-pump (vs onpump) CABG-were significantly associated with the risk of PoAF (in separate analysis) ( Table 2 ). For example, compared with CABG alone, there was a higher risk of PoAF among patients undergoing valvular surgery alone (odds ratio [OR], 1.4; 95% CI, 1.1-1.9) and even higher when valvular surgery is combined with other types of surgery ( Figure 1 ). In addition, there was a significantly higher risk with the use of cardiopulmonary bypass (OR, 2.4; 95% CI, 1.7-3.5) compared with no bypass ( Figure 2) ; use of cardioplegia (OR, 1.7; 95% CI, 1.2-2.5) compared with no cardioplegia; and lower risk with off-pump CABG (OR, 0.62; 95% CI, 0.41-0.96) compared with on-pump CABG.
When we explored interaction, we identified significant interaction between the use of pump (ie, off-pump vs onpump CABG) and 2 of our prespecified variables, that is, sex (P for interaction ¼ .04) and age (P for interaction ¼ .04). Compared with on-pump CABG, offpump CABG was significantly associated with a lower risk of PoAF (OR, 0.53; 95% CI, 0.33-0.85) among men, but there was no significant difference in this risk between on-pump and off-pump CABG among women (OR, 1.7; 95% CI, 0.61-4.5). Likewise, compared with on-pump CABG, off-pump CABG was significantly associated with a lower risk of PoAF among patients aged less than 65 years (OR, 0.35; 95% CI, 0.16-0.75), but there was no significant difference in this risk between on-pump and off-pump CABG among patients aged 65 years or more (OR, 0.88; 95% CI, 0.52-1.5). None of the other interactions as prespecified were statistically significant.
When we combined surgery characteristics and other covariates that showed some univariate association (ie, P<.2) with PoAF in a prediction model, both the type of surgery and the use of cardiopulmonary bypass independently predicted the risk of PoAF (Table 3) . However, off-pump versus on-pump CABG was not included in this model because it was essentially a distinction within a category of patients who underwent CABG (ie, 54% of the total patient population). Other independent predictors of PoAF included age, baseline use of antiarrhythmic, and baseline left atrial diameter (Table 3 ). In comparison, use of cardioplegia was no longer independently associated with risk of PoAF. Similar predictors were identified for PoAF NT but with lower statistical power as expected (Table E3 ).
Surgical and Patient Characteristics and Risk of Major Adverse Cardiovascular Event and Mortality
The incidence of MACE increased from postoperative day 1 to a peak on day 3, and then was lower thereafter ( Figure E2 ). Among surgery characteristics, only the PoAF, Postoperative atrial fibrillation; SD, standard deviation; BMI, body mass index; IQR, interquartile range; Afib, atrial fibrillation; COPD, chronic obstructive pulmonary disease; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting. *Numbers for each type of cardiac surgery are not mutually exclusive, because some patients underwent multiple procedures. yValvular surgery performed includes aortic (69%), mitral (26%), combination of aortic and mitral (4.0%), and others (1.2%).
method of rhythm return was significantly associated with the risk of MACE (Table E4) . Compared with the spontaneous method of rhythm return, the assisted method was associated with a higher risk of MACE (OR, 2.5; 95% CI, 1.2-5.0) (Figure 3 ), and among the 3 assisted methods of rhythm return, ventricular pacing was associated with the Values in bold are statistically significant at P <.05. PoAF, Postoperative atrial fibrillation; OR, odds ratio; CI, confidence interval; CABG, coronary artery bypass grafting; CABG þ valvular, combination of CABG and valvular surgery; CABG þ valvular þ, surgeries involving CABG, valvular, and at least 1 other type of cardiac procedure. *Association between surgery characteristics and incidence of postoperative atrial fibrillation was assessed via multivariable logistic regression. Covariates were included via backward stepwise selection (P exclusion ¼ .20, P inclusion ¼ .10), with forcing of age, sex, race, history of Afib, left atrial diameter, and COPD, and model-based selection of country BMI, hypertension, smoking, heart failure, renal failure, perioperative beta-blocker, statin and antiarrhythmic use, and prior PCI. yP trend<.001 across categories of surgery type as ordered in the (Table 4) , whereas 1-year mortality was predicted by age, sex, COPD, and perioperative statin use (Table 5 ). 
Impact of Postoperative Atrial Fibrillation
In multivariable-adjusted models, occurrence of PoAF was associated with increased resource use, including length of ICU/CCU stay and total hospital stay (Table  E5) . On average, patient with PoAF spent 0.69 (95% CI, 0.43-0.95) more days in the ICU/CCU and 1.3 (95% CI, 0.71-1.9) more total hospital days than those without PoAF. Other predictors of resource use are available in Tables E6 and E7 .
Occurrence of PoAF was significantly associated with 1-year mortality (HR, 2.2; 95% CI, 1.2-3.9) (Figure 5 ), whereas PoAF NT was significantly associated with both 30-day (HR, 3.1; 95% CI, 1.2-7.8) and 1-year mortality (HR, 3.2; 95% CI, 1.2-8.4) ( Table E8) .
DISCUSSION
In this multicenter clinical trial of patients undergoing cardiac surgery in the United States, Italy, and Argentina, we identified specific surgery and patient characteristics that were associated with adverse outcomes of PoAF, MACE, and mortality. We found that the type of surgery and use of cardiopulmonary bypass (including off-pump [vs on-pump] CABG) were associated with PoAF. Among patient factors, age, baseline use of antiarrhythmic, and left atrial diameter independently predicted the risk of PoAF. When additional complications were evaluated, the method of rhythm return was associated with the risk of MACE, whereas the type of surgery was associated with 30-day mortality. Last, we showed that the occurrence of PoAF was associated with increased resource use as defined by ICU/CCU stay and total hospital stay, and mortality.
Our study builds on and considerably extends on findings from prior studies. The results are consistent with prior studies that have shown the incidence of PoAF after cardiac surgery was significantly higher with concomitant CABG and valve surgery, 13, 21 as well as with the use of cardiopulmonary bypass. 22, 23 Furthermore, our study provides novel evidence of a graded increase in the risk of PoAF across the 4 categories of cardiac surgeries as prespecified (ie, from CABG alone through combination of CABG, valvular surgery, and at least 1 other procedure). Although prior studies have suggested a higher risk of PoAF with valve surgery, as well as a combination of CABG and valvular surgery compared with CABG alone, 6, 24 we are not aware of any study to date to demonstrate this graded increase in the risk of PoAF in a multivariable analysis, thereby representing a novel evidence of the additive effect of the different type of cardiac surgery on the pathophysiology or myocardial Values in bold are statistically significant at P <.05. OR, Odds ratio; CI, confidence interval; Afib, atrial fibrillation; COPD, chronic obstructive pulmonary disease; CABG, coronary artery bypass graft; CABG þ valvular, combination of CABG and valvular surgery; CABG þ valvular þ, surgeries involving CABG, valvular, and at least 1 other type of cardiac procedure. *Evaluation for independent predictors was assessed by including all these variables (with P <.2 in a univariate analysis with atrial fibrillation) in a single model. C-statistic for the multivariable model was 0.73. Subgroup variables in Table 2 -valve type, number of bypass grafts, offpump versus on-pump CABG, pump duration, cross duration, cardioplegia dose, number of cardioplegia dose and cardioplegia approach-were not considered for inclusion in the predictive model because including them would restrict analysis to only patients within the subgroup. yOR represents change in the odds per 10-unit increase in the variable. The unit of measurement was years for age and millimeters for left atrial diameter. zHypertension, renal failure, and current smoking became nonsignificant after adjusting for age. xP trend across the categories of surgery type as ordered in the remodeling underlying PoAF. By extending the results of prior studies, 22, 23 we also showed that among patients undergoing CABG, the association of off-pump (vs onpump) CABG with the incidence of PoAF varies with gender and age. Specifically, the lower risk of PoAF with off-pump CABG was only significant in men (but nonsignificant in women), and this protective benefit was evident only among patients aged less than 65 years.
In addition, we provide initial empirical evidence that the method of rhythm return after cardiac surgery is associated with MACE. Specifically, the assisted method of rhythm return (especially ventricular pacing) is significantly associated with a higher risk of MACE. Lack of a coordinated atrial contraction with ventricular pacing has been implicated as a mechanistic link for poor hemodynamic parameters, including low cardiac output, [25] [26] [27] and may underlie the high incidence of MACE after pacing. Although the results on the association between the type of surgery and the combination of surgery on the risk of 30-day mortality have been mixed in the literature, [28] [29] [30] [31] [32] [33] our study demonstrates that in a generalizable patient population, a combination of CABG with valvular surgery is associated with a higher risk of 30-day mortality compared with CABG alone.
Our study has important clinical implications. First, we identified high-risk surgery characteristics and practices that warrant consideration for prophylaxis for PoAF, MACE, and mortality. 34 Although the protective benefits of beta-blockers on PoAF, as well as statins on MACE and 30-day mortality, did not reach statistical significance in our study, prior studies have suggested that these therapies may reduce the risk of these adverse outcomes. [35] [36] [37] [38] In addition, we showed in our study that perioperative statin use significantly lowers the risk of 1-year mortality.
These may be considered for high-risk surgeries, especially when these findings are confirmed in randomized trials. Second, because of the increasing trend in the rate of valvular surgery, as well as the combination of CABG and valvular surgery performed in the United States, 39, 40 our study highlights the need for new guidelines or update to current guidelines (that addressed only isolated CABG) to incorporate these relatively high-risk procedures that we identified to be associated with higher risk of PoAF or mortality compared with isolated CABG in the OPERA trial. 41 In this generalizable patient population undergoing various surgical procedures, we highlighted key independent predictors (including patient and surgery characteristics) of PoAF and mortality that should be considered for risk stratification.
Study Limitations
Potential limitations of this study should be considered. First, the study has a nonrandomized observational design that precludes causal interpretation of the associations. For example, although some of the complications (eg, stroke) are causally related to PoAF, others, such as ICU length of stay, could be a correlate of poor postoperative course. However, given the nature of the research question, it will be impossible to have a randomized design for most of these surgery characteristics because they are selected only by patient-specific indications and postoperative course. We mitigated against possible bias of the associations of interest by adjusting for potential confounders in multivariable analysis. Second, this investigation was performed exclusively in patients undergoing cardiac surgery. Thus, our findings may not be extendable to other thoracic surgeries in which these end points are common.
CONCLUSIONS
We identified surgery and patient characteristics that are associated with adverse clinical outcomes, especially postoperative atrial fibrillation (Video 1). We believe this relatively novel information will facilitate adequate patient education and counseling, inform guidelines for surgical practices, and identify procedures that will require perioperative prophylaxis.
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Acquired: Perioperative Management Akintoye et al Values in bold are statistically significant at P<.05. N, Number of patients; HR, hazard ratio; CI, confidence interval; PoAF NT , new-onset postoperative atrial fibrillation requiring treatment. *Association between PoAF NT and mortality was assessed via Cox proportional hazard model. Covariates were included via backward stepwise selection (P exclusion ¼ .20, P inclusion ¼ .10), with forcing of age, sex, and race, and model-based selection of country, BMI, smoking, hypertension, heart failure, renal failure, COPD, history of Afib, prior PCI, perioperative use of antiarrhythmics, statin, anticoagulant, and beta-blocker use. Likewise, association between postoperative atrial fibrillation and length of stay was assessed via multivariable-adjusted linear regression.
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